WallStreetZenWallStreetZen

NASDAQ: RMTI
Rockwell Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for RMTI

Based on 1 analyst offering 12 month price targets for Rockwell Medical Inc.
Min Forecast
$8.00+318.85%
Avg Forecast
$8.00+318.85%
Max Forecast
$8.00+318.85%

Should I buy or sell RMTI stock?

Based on 1 analyst offering ratings for Rockwell Medical Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RMTI stock forecasts and price targets.

RMTI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$8.00+318.85%2022-08-30

1 of 1

Forecast return on equity

Is RMTI forecast to generate an efficient return?
Company
-163.65%
Industry
24.68%
Market
37.27%
RMTI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RMTI forecast to generate an efficient return on assets?
Company
-48.73%
Industry
9.81%
RMTI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RMTI earnings per share forecast

What is RMTI's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$2.27

RMTI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
RMTI$1.91$8.00+318.85%Buy
HAPP$5.83$3.00-48.54%Strong Buy
BFRI$0.88$7.00+695.45%Strong Buy
CLVR$0.54$2.85+427.78%Buy
YCBD$0.33N/AN/A

Rockwell Medical Stock Forecast FAQ

Is Rockwell Medical Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RMTI) stock is to Buy RMTI stock.

Out of 1 analyst, 0 (0%) are recommending RMTI as a Strong Buy, 1 (100%) are recommending RMTI as a Buy, 0 (0%) are recommending RMTI as a Hold, 0 (0%) are recommending RMTI as a Sell, and 0 (0%) are recommending RMTI as a Strong Sell.

If you're new to stock investing, here's how to buy Rockwell Medical stock.

What is RMTI's earnings growth forecast for 2023-2023?

(NASDAQ: RMTI) Rockwell Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Rockwell Medical's earnings in 2023 is -$25,260,000.

In 2023, RMTI is forecast to generate -$26,406,168 in earnings, with the lowest earnings forecast at -$26,406,168 and the highest earnings forecast at -$26,406,168.

What is RMTI's forecast return on equity (ROE) for 2023-2023?

(NASDAQ: RMTI) forecast ROE is -163.65%, which is considered weak.

What is RMTI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RMTI price target, the average RMTI price target is $8.00, with the highest RMTI stock price forecast at $8.00 and the lowest RMTI stock price forecast at $8.00.

The Wall Street analyst predicted that Rockwell Medical's share price could reach $8.00 by Aug 30, 2023. The average Rockwell Medical stock price prediction forecasts a potential upside of 318.85% from the current RMTI share price of $1.91.

What is RMTI's Earnings Per Share (EPS) forecast for 2023-2023?

(NASDAQ: RMTI) Rockwell Medical's current Earnings Per Share (EPS) is -$2.79. In 2023, RMTI's EPS is forecast to hit -$2.27 (min: -$2.27, max: -$2.27).

What is RMTI's forecast return on assets (ROA) for 2023-2023?

(NASDAQ: RMTI) forecast ROA is -48.73%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 9.81%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.